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ABSTRACT
An increasing number of Indians are living with renal disease.
This disease has many implications for, in terms of oral
manifestations and management of afflicted patients. Renal
failure can give rise to a large spectrum of oral manifestations,
affecting the hard or soft tissues of the mouth. The dental care
of these patients can be complex, given the medications
associated with the disease and the medical conditions that
result from inadequately functioning kidneys. Thus, the role of
dentist is pivotal in overall health care of patients with renal
disease. The authors present relevant information to help
dentists in treating patients who exhibit the oral and systemic
manifestations of renal disease. The present article reviews, in
detail, the current knowledge of the oral and dental aspects of
renal failure.
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INTRODUCTION
Diseases of kidney that alter normal functions may be
reversible or irreversible (acute and chronic renal failure
ends stage renal disease). Chronic kidney disease (CKD)
and end stage renal disease (ESRD) are associated with
increased morbidity and mortality.1 In United Kingdom, the
annual incidence of ESRD has doubled over the past decade
to reach about 100 new patients per million of population.
These trends are similar in other developed countries and
are expected to rise at an annual rate of around 5 to 8%.
Two factors are imperative. The first is the ageing of the
population; the incidence of ESRD is higher in elderly
people than in the general population. The second factor is
the global epidemic of type 2 diabetes mellitus; the number
of people with diabetes worldwide (currently about 154 million)
is predicted to double within the next 20 years. This increase
will be most notable in less developed countries, where the
number of diabetic patients could rise from 99 to 286 million
by 2025.2 The population of India exceeds 1 billion and is
expected to become a major reservoir of chronic diseases
like diabetes and hypertension. Since 25 to 40% of these
subjects may develop CKD and ESRD, the burden will rise
and health care professionals need to take care of them.3
The exact prevalence of CKD and ESRD in India is not
clear in the absence of countrywide registry data.3 The
therapy of CKD and ESRD is very expensive and it is out
of reach of 90% patients in India.4 There are many more
people undergoing dialysis treatment and kidney transplants
than there were only a decade ago.5 The dental care of these
patients can be complex, given the medications associated
with the diseases and the medical conditions that result from
inadequately functioning kidneys. Renal diseases have many
implications for dentistry, in terms of oral manifestations
and management of patients. The authors present relevant
information to help dentists treat patients who exhibit the
oral and systemic manifestations of renal diseases.
Renal Failure
Kidney function has deteriorated to the point of chronic
abnormalities in the internal environment, including
azotemia, metabolic acidosis, hypocalcemia and hyper-
phosphatemia as well as isosthenuria and nocturia.6
Chronic renal failure is an irreversible deterioration in
renal function which classically develops over a period of
years. Initially, it is manifest only as a biochemical
abnormality. Eventually, loss of the excretory, metabolic
and endocrine functions of the kidney leads to the
development of clinical symptoms and signs of renal failure,
which are sometime referred to uremia.7 The systemic signs
of renal failure and uremia can be important to the dental
practitioner, particularly hematologic changes, change
in bone metabolism and alterations in immune status
(Table 1).
End Stage Renal Disease
ESRD is that stage of kidney impairment which is
irreversible, cannot be controlled by conservative
management alone, and requires dialysis or kidney
transplantation to maintain life.8
10.5005/jp-journals-10026-1045
Table 1: Signs and symptoms of renal failure and uremia9
Signs Symptoms
Peripheral edema ‘Restless’ legs
Rise in blood pressure (hypertension) Leg cramps
Pericardial effusion Ankle edema
Confusion, coma, lethargy Loss of libido
Renal osteodystrophy Feeling cold
Pallor due to anemia Pruritus
Bruising due to platelet dysfunction10 Insomnia
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Medical Management of Patient with
Renal Failure
The treatment of renal failure includes dietary changes,
correction of systemic complications and dialysis or renal
graft receipt. Since the condition is chronic, the treatment
schedule is bound to be a long time affair. Diet should
therefore contain a moderate amount of proteins except
during periods of acute exacerbations. Rest of the calories
should be derived from carbohydrates. Fats should be
restricted. Anemia should be corrected by repeated pack
cells transfusions. Renal rickets osteomalacia is treated by
massive doses of vitamin D. Serum calcium and serum
alkaline phosphatase levels should be estimated frequently
in order to avoid development of hypercalcemia and its
metastatic complications. Hyperphosphatemia may be
prevented by restricting phosphate containing foods (e.g.
milk, cheese, eggs) and use of phosphate binding drugs,
such as aluminum hydroxide gel (30-60 ml) given after
meals. Intercurrent infection, if any, should be promptly
treated with a suitable antibiotic. Anabolic steroids (e.g.
nandrolone 25 mg intramuscularly once or twice a week)
are useful and help to bring down the raised blood urea level.11
Hypertension and associated cardiovascular complications
should be treated on the usual lines. The dose of digoxin in
case of associated cardiac failure should be low. Nausea and
vomiting may be controlled by chlorpromazine. Hiccups
may at times be difficult to control. Gastric lavage with a
weak solution of sodium solution of sodium bicarbonate
may be helpful. Uremic diarrhea should be treated by high
bowel wash with plain water. Bland antidiarrheal drugs,
such as pectin or kaolin, may be required.11 Renal failure is
a devastating medical, social and economic problem for
patients and their families. The availability and quality of
dialysis programs largely depend on the prevailing economic
conditions, overall health care facilities and the health care
funding strategies of various countries.
Dialysis
Dialysis is a method by which waste products of metabolism
are mechanically washed out of blood. Dialysis is of two
types:
1. Extracorporeal or hemodialysis
2. Intracorporeal or peritoneal dialysis.
Recent Advances in Dialysis
Hemofiltration: This is the most recent technique of dialysis,
where the cannula is inserted into a major artery (usually
the radial) and another cannula into the vein (to form an
AV shunt). The advantages of this technique is that it serves
the purpose of IV feeding as well as is less likely to cause
hypotension in patients with gross septicemia or myocardial
disease (as it likely to happen with hemodialysis).11
Renal Transplant
In recent years, attempts have been made to change the
kidneys altogether, if these are damaged permanently and
irreversibly. The damaged kidneys are replaced by kidneys
obtained from a person having an identical genetic
background, such as identical twins (isograft) or from a
person having a different genetic background (allograft).
Renal transplant is being tried as a means of treating an
irreversibly damaged bilateral renal patients.11
ORAL MANIFESTATIONS
Xerostomia, or dry mouth, is a frequent and important
complaint among dialysis patients.12 Methods to improve
xerostomia might include recommending chewing gum, or
a saliva substitute. Patient with chronic xerostomia require
regular dental checkup as it predisposes to sialadentitis,
caries, oral inflammation and infection.13 Xerostomia also
may give rise to the bad taste and ammonia-like odor, altered
taste sensation or a metallic taste.12
Uremic Stomatitis
Patients who have chronic renal failure typically show
markedly elevated levels of urea and other nitrogenous
wastes in the blood stream. Uremic stomatitis represents a
relatively uncommon complication of renal failure. The
onset may be abrupt, with white plaques distributed
predominantly on the buccal mucosa, tongue and floor of
the mouth (Fig. 1).14 Patients may complain of unpleasant
taste, oral pain or a burning sensation with the lesions, and
the clinician may detect an odor of ammonia or urine on
the patient’s breath. The clinical appearance occasionally
has been known to mimic oral hairy leukoplakia.14
Fig. 1: Uremic frost
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Uremic stomatitis and uncommon clinical observation
associated to uremia. As many as four types of uremic
stomatitis have been described: Erythemopultaceous,
ulcerative, hemorrhagic hyperkeratotic.15
Renal Osteodystrophy
A frequent long-term complication of renal disease is renal
osteodystrophy, a spectrum of bone metabolism disorders
associated with different pathogenic pathways.16 These
changes comprise bone demineralization with trabeculation
and cortical loss, giant cell radiotransparencies or metastatic
calcifications of the soft tissues. The patients are at increased
risk of fracture during dental treatments, such as
extractions.17 Diffuse involvements of the jaws occur with
significant frequency and radiographic alterations of the
facial skeleton may represent one of the earliest signs of
the disease.16 In some patients, marked jaw enlargement
and malocclusion may occur.
• Delayed eruption
• Enamel hypoplasia (Fig. 2)14
• Loss of the lamina dura
• Widening of the periodontal ligament





Dental anomalies associated with renal failure, tooth and
periodontium.
Fungal Infections
Oral candidiasis will affect 20 to 30% transplant patients.18,19
Candidal infection may present as angular cheilitis,
pseudomembranous or erythematous ulceration or chronic
atrophic infection.11 Prevention is effective in the early post-
transplant period with antifungal lozenges or solutions.
Treatment depends on severity; lozenges may cure mild
infections, but oral antifungal may be required. Viral infection,
such as herpes simplex virus used to be common in transplant
recipients; the use of antiherpetic agents, such as acyclovir
has significantly reduced the frequency of these infections.12
Oral Malignancy
An increased susceptibility to epithelial dysplasia and
carcinoma of the lip attributable to the treatment following
renal transplantation has been postulated. The increased risk
of malignancy in CRF probably reflects the effects of
iatrogenic immune suppression, which in turn increases
mucosal susceptibility to virus-related tumors, such as
Kaposi’s sarcoma or non-Hodgkin lymphoma.20
Mucosal Lesions
A variety of oral mucosal lesions, particularly white patches,
ulceration has been noted in individuals receiving dialysis
and renal transplant. In particular, lichen planus-like lesion
(lichenoid disease), oral hairy leukoplakia can occur
secondary to drug-related immunosuppression (e.g.
diuretics, beta-blockers). Epstein-Barr virus (EBV) has been
observed with uremia, this lesion may resolve with
correction of the uremia.10 White patches often related with
the skin, called ‘uremic frost,’ can occasionally be seen
intraorally. This uremic frost results from remaining urea
crystals left on epithelial surfaces following perspiration
and saliva evaporation.6
Periodontal Disease
Effects of chronic renal disease and renal transplant on
periodontal tissues include gingival hyperplasia and
increased levels of plaque, calculus and gingival
inflammation and possible increased prevalence and severity
of destructive periodontal diseases.21
Gingival hyperplasia secondary to calcineurin inhibitors
and calcium channel blockers are the most reported effect
of renal disease on periodontal tissues. Gingival overgrowth
with these drugs can be severe and treatment frequently
requires surgical resection. Hyperplasia mainly affects the
labial surface of the interdental papilla, though greater
extensions can be affected, including the gingival margins
and lingual and palatal surfaces9 (Fig. 3).14 Improved oral
hygiene has been reported to decrease the incidence or delay
the onset of gingival hyperplasia; gingival bleeding,
petechiae and ecchymosis, resulting from platelet
dysfunction and the effects of anticoagulants;22 periodontal
problems with important attachment loss, recesses and deep
pockets.21Fig. 2: Enamel hypoplasia
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Dental Considerations
The main management problems in renal failure include
the following:
Bleeding Tendencies
Careful hemostasis should be ensured, if oral surgical
procedures are necessary. Dental treatment is best carried
out on the day after dialysis when there has been maximal
benefit from dialysis and the effect of the heparin has worn
off. The hematologist should be first consulted. Should
bleeding be prolonged, desmopressin may provide
hemostasis for up to 4 hours. If fails, cryoprecipitate may
be effective, has a peak effect at 4 to 12 hours and lasts up
to 36 hours. Conjugated estrogens may aid in hemostasis:
The effect takes 2 to 5 days to develop, but persists for
30 days.23
Infections
They are poorly controlled by the patient with renal failure,
especially if the patient is immunosuppressed, and may
spread locally as well as giving rise to septicemia. Infections
are difficult to recognize as signs of inflammation are
masked. Hemodialysis predisposes to blood borne viral
infection, such as hepatitis virus.
Antimicrobials consideration include erythromycin,
cloxacillin, fucidin and can be given in standard dosage.
Penicillin, metronidazole and cephaloridine should be given
in lower doses, since very high serum levels can be toxic to
the central nervous system. Benzyl penicillin has significant
potassium content and may be neurotoxic and therefore
contraindicated. Patients should be considered for
antimicrobials prophylaxis before extraction, scaling or
periodontal surgery for those with polycystic kidney, those
receiving peritoneal dialysis, since bacteremia can result in
peritonitis. Aspirin and other nonsteroidal anti-inflammatory
analgesics should be avoided, since they aggravate
gastrointestinal irritation and bleeding associated with renal
failure. Their excretion may also be delayed and they may
be nephrotoxic, especially in the elderly or in renal damage
or cardiac failure. Some patients have peptic ulceration,
which is further contraindication to aspirin. Even COX-2
inhibitors may be nephrotoxic and are best avoided.
Antihistamines or drugs with antimuscarinic side effects
may cause dry mouth urinary retention. Fluorides can safely
be given topically for caries prophylaxis. Systemic fluorides
should not be given, because of doubt about fluoride
excretion by damaged kidney. Antacids containing
magnesium should not be given as there may be magnesium
retention. Antacids containing calcium or aluminium bases
may impair absorption of penicillin and sulphonamides. 23,24
Hypertension
Many renal patients are on antihypertensive therapy, digoxin
and diuretics which may also complicate management.
Local Anesthesia and Conscious Sedation
Local anesthesia is safe unless there is severe bleeding
tendency.
Conscious sedation: Relative analgesia may be used.
Midazolam is preferable to diazepam because of the lower
risk of thrombophlebitis.25
General Anesthesia
Renal failure is complicated by anemia, which is the
contraindication to general anesthesia, if the hemoglobin is
below 10gm/dl. Some of the difficulties with general
anesthesia are the patients with chronic renal failure which
are highly sensitive to the myocardial depressant effects of
anesthetic agents and may develop hypotension at moderate
levels of anesthesia. Isoflurane and sevoflurane are safer.
Induction with thiopentone followed by very light general
anesthesia with nitrous oxide is generally the technique of
choice.23,24
To reduce dry mouth, recommended use of alcohol-free
mouthwashes or saliva substitute is advocated.
All universal precautions should be followed as
incidence of hepatitis B and C are higher among dialysis
patients.24
CONCLUSION
The goal of dental treatment in patients with renal disease
should be early and frequent evaluation of the oral cavity
for the source of infection. Early detection of oral
pathologies will permit swift correction without the need
Fig. 3: Drug-induced gingival enlargement
MK Sunil et al
220
JAYPEE
of extensive treatment. The dentist must be aware of the
ramifications of renal disease and hemodialysis on dental
treatment. The dental management of renal failure is
complicated by some systemic consequences, such as
anemia, bleeding tendencies and cardiovascular or endocrine
disease. The renal disease patients having dental problems
may compromise his/her general health and hinder medical
treatment. Thus, the role of dentist is pivotal in overall health
care of patients with renal diseases.
Source of pictures: Neville BW, Damm DD, Allen CM. Oral
manifestation of systemic diseases. Textbook of Oral and
Maxillofacial Pathology (2nd ed). USA: WB Saunders
Company 2002;705-36.
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